Track the VISEN Pharmaceuticals - B share price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. Operating in the Health Care sector, VISEN Pharmaceuticals - B has published 2 public disclosures. Market capitalisation: €2.3bn. The latest transaction was disclosed on 28 April 2026 (Sale). Among the most active insiders: LU AN-BANG. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
VISEN Pharmaceuticals - B is a company focused on developing innovative treatments in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange (XHKG).